Rodríguez-Pontones JA, Bretón-Reyes D

Language: Spanish
References: 13
Page: 167-172
PDF size: 77.58 Kb.

ABSTRACT

Introduction: For the treatment of obstructive hydronephrosis that compromises renal function, procedures are required to decrease pressure such as intrarenal ultrasound-guided percutaneous nephrostomy, which leads to complications like any procedure. General objective: To determine the complications of patients undergoing ultrasound-guided percutaneous nephrostomy and factors associated with their development. Material and methods: Cross-analytical, observational, retrospective study that included patients undergoing ultrasound-guided percutaneous nephrostomy in UMAE 25 IMSS, from 1 March, 2013 to 1 March, 2014. Electronic medical records were obtained: age, gender, history of diabetes mellitus, hypertension, smoking, and alcoholism, and whether or not there was the development of post-procedure complications. The association was analyzed by chi square test and Student’s t test, taking as significant a value of p = 0.05 and the magnitude of association was measured with 95% confidence interval with SPSS v.18.0. Results. A total of 84 patients aged 31-79 years were analyzed, corresponding to 64.3% of women. Nephrostomy subsequent complications occurred in 19.0% of cases, of which diabetes mellitus comorbidities occurred in 56.2%, hypertension in 62.5%, obesity 75.0%, smoking 31.2%, and alcoholism 43.7%, with a statistically significant association (p = 0.019), with the presence of obesity hematuria being the most commonly observed complication. Conclusion: Despite the presence of several comorbidities in our population, only the influence of obesity was associated with the development of complications in patients who underwent ultrasound-guided nephrostomy.

REFERENCES

1. Ramchandani P, Cardella J, Grassi C, et al. Society of Interventional Radiology Standards of Practice Committee Quality improvement guidelines for percutaneous nephrostomy. J Vasc Interv Radiol. 2003;14(9 Pt 2):277-81.

2. Farrell T, Hicks M. A review of radiologically guided percutaneous nephrostomies in 303 patients. J Vasc Interv Radiol. 1997;8(5):769-74.

3. Klahr S. Pathophysiology of obstructive nephropathy. Kidney Int. 1983;23(2):414-26.

4. Vaughan E, Marion D, Poppas D, Felsen D. Pathophysiology of unilateral ureteral obstruction: studies from Charlottesville to New York. J Urol. 2004;172(6 Pt 2):2563-9.

5. Pearle M, Pierce H, Miller G, et al. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. J Urol. 1998;160(4):1260-4.

6. Baishya RK, Dhawan DR, Jagtap J, et al. Percuthaneous nephrostomy under ultrasound guidance. Indian J Nephrol. 2011;21(1):67-71.

7. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.

8. Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21(4):556-63.

9. Mise K, Hoshino J, Ubara Y, et al. Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy. Nephrol Dial Transplant. 2014;29(1):109-18.

10. Byun JM, Lee CH, Lee SR, et al. Renal outcomes and clinical course of nondiabetic renal diseases in patients with type 2 diabetes. Korean J Intern Med. 2013;28(5):565-72.

11. Iwakiri T, Sato Y, Matsuura Y, Hatakeyama K, et al. Association between renal vasculature changes and generalized atherosclerosis: an autopsy survey. J Atheroscler Thromb. 2014;21(2):99-107.

12. Gonzalez V, Saldías R, Castillo O. Utilización de la nefrostomía percutánea en la práctica clínica urológica. Rev Chil Uro. 2009;74(3):34-45.

13. Dyer RB, Regan JD, Kavanagh PV, Khatod EG, Chen MY, Zagoria RJ. Percutaneous nephrostomy with extensions of the technique: Step by step. Radiographics. 2002;22(3):503-25.